Alaa Mostafa Sewefy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alaa Mostafa Sewefy has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Ahmed M. Atyia
Department of Surgery, Minia University Hospital, Minia, Egypt
5 shared publications- Ahmed Zaid
Wadi Al Dawasir Armed Forces Hospital, Wadi Al Dawasir, Saudi Arabia
2 shared publications - Ayman El Nakeeb
Gastroenterology Surgical Center, Mansoura University, Mansoura, Egypt
2 shared publications - Hassan Aldossary
Wadi Al Dawasir Armed Forces Hospital, Wadi Al Dawasir, Saudi Arabia
2 shared publications Karim Sabry
Faculty of Medicine, Ain Shams University, Cairo, Egypt
2 shared publications- Mohamad Elrefai
Gastrointestinal Surgical Center, Department of Surgery, Faculty of Medicine, Mansoura University, Al Mansurah, Egypt.
2 shared publications
Latest Publications
- Open Access
- 6 April 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36  (5) , 2180-2190
Naturally Banded Sleeve Gastrectomy Vs Non-Banded Sleeve Gastrectomy, Two Years Follow up, Controlled Clinical Trial
Introduction: Laparoscopic sleeve gastrectomy (LSG) is the most common bariatric procedure. Although ring-augmented LSG reportedly improves long-term weight-loss outcomes, some are concerned about potential complications related to the foreign body. Therefore, this study aimed to examine 2 years of follow-up of banded sleeve with the patient’s own tissue, naturally banded LSG. Methods: This prospective randomized controlled clinical trial enrolled 80 patients. It was conducted at a university hospital between November 2022 and January 2025. Patients were randomly assigned to two equal groups: Group 1, LSG plus banding using the Teres ligament or a tight omental flap, and Group 2, LSG without banding. Patients were followed up for at least 2 years. Results: The mean follow-up period was 25.5 months. At 2 years, the mean gastric volume was significantly smaller in Group 1 (142.3 mL) than in Group 2 (218.7 mL, p = 0.000). Additionally, the mean percentage of excess weight loss (%EWL) was significantly higher in Group 1 (87.0%) than in Group 2 (81.8%, p = 0.000). Moreover, the mean percentage of total weight loss (%TWL) was significantly higher in Group 1 (42.0%) than in Group 2 (38.0%, p = 0.034). Finally, the mean food tolerance score was significantly lower in Group 1 (21.5) than in Group 2 (22.9, p = 0.000). Conclusions: Based on 2 years of follow-up, LSG with natural banding was associated with minimal gastric pouch dilatation and greater weight loss than non-banded LSG. However, long-term follow-up data are needed.
- 6 April 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36  (5) , 2180-2190
Open AccessNaturally Banded Sleeve Gastrectomy Vs Non-Banded Sleeve Gastrectomy, Two Years Follow up, Controlled Clinical Trial
Introduction: Laparoscopic sleeve gastrectomy (LSG) is the most common bariatric procedure. Although ring-augmented LSG reportedly improves long-term weight-loss outcomes, some are concerned about potential complications related to the foreign body. Therefore, this study aimed to examine 2 years of follow-up of banded sleeve with the patient’s own tissue, naturally banded LSG. Methods: This prospective randomized controlled clinical trial enrolled 80 patients. It was conducted at a university hospital between November 2022 and January 2025. Patients were randomly assigned to two equal groups: Group 1, LSG plus banding using the Teres ligament or a tight omental flap, and Group 2, LSG without banding. Patients were followed up for at least 2 years. Results: The mean follow-up period was 25.5 months. At 2 years, the mean gastric volume was significantly smaller in Group 1 (142.3 mL) than in Group 2 (218.7 mL, p = 0.000). Additionally, the mean percentage of excess weight loss (%EWL) was significantly higher in Group 1 (87.0%) than in Group 2 (81.8%, p = 0.000). Moreover, the mean percentage of total weight loss (%TWL) was significantly higher in Group 1 (42.0%) than in Group 2 (38.0%, p = 0.034). Finally, the mean food tolerance score was significantly lower in Group 1 (21.5) than in Group 2 (22.9, p = 0.000). Conclusions: Based on 2 years of follow-up, LSG with natural banding was associated with minimal gastric pouch dilatation and greater weight loss than non-banded LSG. However, long-term follow-up data are needed.
- Open Access
- 26 May 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111  (8) , 5268-5279
Single anastomosis sleeve jejunal (SAS-J) bypass vs single anastomosis sleeve ileal (SASI) bypass, prospective randomized controlled clinical trial
Background: Single anastomosis sleeve ileal (SASI) bypass is a modification of Santoro’s operation. Which aimed to keep normal food pathway and allow endoscopic examination. The procedure was modified to single anastomosis sleeve jejunal (SAS-J) bypass to minimize the nutritional deficiency. The study aimed to compare SASI to SAS-J bypass. Materials and methods: This was a prospective randomized controlled trial that included 180 patients. Patients were randomly assigned to two equal groups: Group 1, was operated with SASI bypass while Group 2 was operated with SAS-J bypass. All patients complete at least 1 year of follow-up. Results: A total of 63% of patients were female and 37% were male. The mean body mass index was 47.6. The mean age was 36 years. The total incidence of malnutrition was 58% in Group 1 vs 27.6% in Group 2 ( P = 0.000). Protein malnutrition occurred in 15.9% of Group 1 vs 4.6% in Group 2 ( P = 0.014). Anemia occurred in 14.8% in Group 1 vs 5.7% in Group 2 ( P = 0.049). %EWL at 1 year was 94.8 in Group 1 vs 90.6 in Group 2 ( P = 0.005). Diarrhea occurred in 21.6% in Group 1 vs 8% in Group 2 ( P = 0.012). The incidence of excessive weight loss was 11.4% in Group 1 vs 2.3% in Group 2 ( P = 0.0031). The rate of reoperation was 11.4% in Group 1 vs 2.3% in Group 2 ( P = 0.018). Conclusions: Both SASI and SAS-J bypass are effective as a metabolic and a weight loss surgery, but, SAS-J bypass is associated with less nutritional deficiency and less complications rate compared to SASI bypass.
- 26 May 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111  (8) , 5268-5279
Open AccessSingle anastomosis sleeve jejunal (SAS-J) bypass vs single anastomosis sleeve ileal (SASI) bypass, prospective randomized controlled clinical trial
Background: Single anastomosis sleeve ileal (SASI) bypass is a modification of Santoro’s operation. Which aimed to keep normal food pathway and allow endoscopic examination. The procedure was modified to single anastomosis sleeve jejunal (SAS-J) bypass to minimize the nutritional deficiency. The study aimed to compare SASI to SAS-J bypass. Materials and methods: This was a prospective randomized controlled trial that included 180 patients. Patients were randomly assigned to two equal groups: Group 1, was operated with SASI bypass while Group 2 was operated with SAS-J bypass. All patients complete at least 1 year of follow-up. Results: A total of 63% of patients were female and 37% were male. The mean body mass index was 47.6. The mean age was 36 years. The total incidence of malnutrition was 58% in Group 1 vs 27.6% in Group 2 ( P = 0.000). Protein malnutrition occurred in 15.9% of Group 1 vs 4.6% in Group 2 ( P = 0.014). Anemia occurred in 14.8% in Group 1 vs 5.7% in Group 2 ( P = 0.049). %EWL at 1 year was 94.8 in Group 1 vs 90.6 in Group 2 ( P = 0.005). Diarrhea occurred in 21.6% in Group 1 vs 8% in Group 2 ( P = 0.012). The incidence of excessive weight loss was 11.4% in Group 1 vs 2.3% in Group 2 ( P = 0.0031). The rate of reoperation was 11.4% in Group 1 vs 2.3% in Group 2 ( P = 0.018). Conclusions: Both SASI and SAS-J bypass are effective as a metabolic and a weight loss surgery, but, SAS-J bypass is associated with less nutritional deficiency and less complications rate compared to SASI bypass.
- 22 November 2023
- Published by Springer Nature in Obesity Surgery
- Vol. 34  (1) , 183-191
Impact of Helicobacter pylori Status on Postoperative Morbidities After Laparoscopic Sleeve Gastrectomy in an Endemic Region (a Retrospective Multicentric Study)
Purpose Studies are still ongoing to determine whether Helicobacter pylori (HP) may affect the results of laparoscopic sleeve gastrectomy (LSG). The main research objectives were HP prevalence in patients with severe obesity and the effects of HP status on outcomes. Patients and Methods This multicenter retrospective study included patients with severe obesity who had LSG. The patients were grouped into three groups based on the HP status of preoperative endoscopic biopsies and postoperative specimen results: group I (negative HP), group II (eradicated HP), and group III (positive HP). The primary outcome was the overall postoperative morbidities. Results One thousand six hundred fifteen patients who underwent LSG for severe obesity were included in this study. Seven hundred fifty (46.4%) patients had negative HP, and 637 (39.4%) patients had eradicated HP, whereas 228 (14.1%) patients had positive HP. The antral and gastric body wall thickness was significantly noticed with positive HP. The groups had no significant differences regarding postoperative complication frequency, severity, and hospital mortality. The rates of gastric leakage in the three groups do not differ significantly. BMI > 50, gastropexy, gastric thickness, and antral resection were found to be independent risk factors for the occurrence of postoperative complications after LSG. There was no statistical significance as regards postoperative %TWL and %EWL among the three groups. Conclusion The early results of LSG do not appear to be impacted by HP’s status. The early postoperative course is unaffected by HP eradication anymore. Therefore, routine preoperative HP testing may not be as necessary, and management can be finished after LSG. Graphical Abstract
- 22 November 2023
- Published by Springer Nature in Obesity Surgery
- Vol. 34  (1) , 183-191
Impact of Helicobacter pylori Status on Postoperative Morbidities After Laparoscopic Sleeve Gastrectomy in an Endemic Region (a Retrospective Multicentric Study)
Purpose Studies are still ongoing to determine whether Helicobacter pylori (HP) may affect the results of laparoscopic sleeve gastrectomy (LSG). The main research objectives were HP prevalence in patients with severe obesity and the effects of HP status on outcomes. Patients and Methods This multicenter retrospective study included patients with severe obesity who had LSG. The patients were grouped into three groups based on the HP status of preoperative endoscopic biopsies and postoperative specimen results: group I (negative HP), group II (eradicated HP), and group III (positive HP). The primary outcome was the overall postoperative morbidities. Results One thousand six hundred fifteen patients who underwent LSG for severe obesity were included in this study. Seven hundred fifty (46.4%) patients had negative HP, and 637 (39.4%) patients had eradicated HP, whereas 228 (14.1%) patients had positive HP. The antral and gastric body wall thickness was significantly noticed with positive HP. The groups had no significant differences regarding postoperative complication frequency, severity, and hospital mortality. The rates of gastric leakage in the three groups do not differ significantly. BMI > 50, gastropexy, gastric thickness, and antral resection were found to be independent risk factors for the occurrence of postoperative complications after LSG. There was no statistical significance as regards postoperative %TWL and %EWL among the three groups. Conclusion The early results of LSG do not appear to be impacted by HP’s status. The early postoperative course is unaffected by HP eradication anymore. Therefore, routine preoperative HP testing may not be as necessary, and management can be finished after LSG. Graphical Abstract
- 23 June 2023
- Published by Springer Nature in Obesity Surgery
- Vol. 33  (8) , 2602-2607
The Impact of Blood Pressure Switching (from Controlled Hypotension to Late Elevated Blood Pressure) During Laparoscopic Sleeve Gastrectomy: Controlled Clinical Trial
Purpose Laparoscopic sleeve gastrectomy (LSG) is the most done bariatric procedure. Bleeding and leak are the most common associated complications. Elevation of systolic blood pressure (SBP) leads to discovering the bleeding sites but results in a bloody field and increases the operative time. Controlled hypotension shortens the operative time, reduces tissue edema, and improves field vision. We aimed to test controlled hypotension during LSG. Material and Methods This was a randomized controlled trial that included 200 patients who were operated by LSG, randomly assigned to 2 equal groups: group 1, operated with controlled hypotensive anesthesia, and group 2, operated with elevated SBP to 140 mmHg. Results Of the patients, 162 (81%) were females, and 38 (19%) were male. The mean BMI was 45.7 kg/m2. The mean age was 41.7 years. The operative time was 36.43 ± 6.73 min in group 1 vs. 44.71 ± 5.47 min in group 2. The mean of total number of used gauzes and clips was 2.70 ± 3.49 in group 1 vs. 8.83 ± 3.15 in group 2. The mean amount of drain output was 37.65 ± 21.90 ml in group 1 vs. 74.00 ± 16.54 ml in group 2. The mean drop in the postoperative hematocrit was 0.08 in group 1 vs. 0.22 in group 2. The incidence of postoperative bleeding was 0% in group 1 vs. 1% in group 2. Conclusions Controlled hypotensive anesthesia in LSG reduces the operative time, reduces the intraoperative bleeding, and improves the operative field. Graphical Abstract
- 23 June 2023
- Published by Springer Nature in Obesity Surgery
- Vol. 33  (8) , 2602-2607
The Impact of Blood Pressure Switching (from Controlled Hypotension to Late Elevated Blood Pressure) During Laparoscopic Sleeve Gastrectomy: Controlled Clinical Trial
Purpose Laparoscopic sleeve gastrectomy (LSG) is the most done bariatric procedure. Bleeding and leak are the most common associated complications. Elevation of systolic blood pressure (SBP) leads to discovering the bleeding sites but results in a bloody field and increases the operative time. Controlled hypotension shortens the operative time, reduces tissue edema, and improves field vision. We aimed to test controlled hypotension during LSG. Material and Methods This was a randomized controlled trial that included 200 patients who were operated by LSG, randomly assigned to 2 equal groups: group 1, operated with controlled hypotensive anesthesia, and group 2, operated with elevated SBP to 140 mmHg. Results Of the patients, 162 (81%) were females, and 38 (19%) were male. The mean BMI was 45.7 kg/m2. The mean age was 41.7 years. The operative time was 36.43 ± 6.73 min in group 1 vs. 44.71 ± 5.47 min in group 2. The mean of total number of used gauzes and clips was 2.70 ± 3.49 in group 1 vs. 8.83 ± 3.15 in group 2. The mean amount of drain output was 37.65 ± 21.90 ml in group 1 vs. 74.00 ± 16.54 ml in group 2. The mean drop in the postoperative hematocrit was 0.08 in group 1 vs. 0.22 in group 2. The incidence of postoperative bleeding was 0% in group 1 vs. 1% in group 2. Conclusions Controlled hypotensive anesthesia in LSG reduces the operative time, reduces the intraoperative bleeding, and improves the operative field. Graphical Abstract
- 10 September 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32  (11) , 3541-3550
Prevalence, Predictors, and Management of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy: a Multicenter Cohort Study
Background One of the most popular bariatric procedures is laparoscopic sleeve gastrectomy (LSG), which can either cause or worsen gastroesophageal reflux disease (GERD). Therefore, the goal of this study was to examine the prevalence, predictors, and management of GERD symptoms after LSG. Materials and Methods From January 2017 to January 2022, we looked at patients who had a primary LSG and developed GERD. Before LSG, all patients underwent a barium meal and upper endoscopy. After LSG, barium meal, endoscopy, esophageal manometry, and 24-h pH measurements were performed for selected patients. The diagnosis of GERD is based on the GERD-HRQL questionnaire and upper endoscopy. Results The study included 1537 patients (62.5% women and 37.5% men) with a mean age of 34.4 years. The mean % TWL was 40.7% during a mean follow-up period of 15.9 months. A total of 379 patients (24.7%) experienced postoperative GERD, of whom 328 (21.3%) had postoperative de novo GERD symptoms, 25 (1.6%) had worsened preoperative GERD, and 26 (1.7%) had the same preoperative GERD symptoms. Antral preservation and gastropexy were protective factors against the development of GERD after LSG. LSG was converted to LRYGB in 15.8% of the patients with GERD. The response to medical treatment was observed in 300 (79.2%) patients with GERD. Conclusion Post-LSG GERD presented in 379 patients (24.7%). Antral preservation and gastropexy were protective factors for the development of postoperative GERD after LSG. Medical treatment was the main line of treatment for GERD. Trial registration ClinicalTrials.gov ID: NCT05416645. Graphical abstract
- 10 September 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32  (11) , 3541-3550
Prevalence, Predictors, and Management of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy: a Multicenter Cohort Study
Background One of the most popular bariatric procedures is laparoscopic sleeve gastrectomy (LSG), which can either cause or worsen gastroesophageal reflux disease (GERD). Therefore, the goal of this study was to examine the prevalence, predictors, and management of GERD symptoms after LSG. Materials and Methods From January 2017 to January 2022, we looked at patients who had a primary LSG and developed GERD. Before LSG, all patients underwent a barium meal and upper endoscopy. After LSG, barium meal, endoscopy, esophageal manometry, and 24-h pH measurements were performed for selected patients. The diagnosis of GERD is based on the GERD-HRQL questionnaire and upper endoscopy. Results The study included 1537 patients (62.5% women and 37.5% men) with a mean age of 34.4 years. The mean % TWL was 40.7% during a mean follow-up period of 15.9 months. A total of 379 patients (24.7%) experienced postoperative GERD, of whom 328 (21.3%) had postoperative de novo GERD symptoms, 25 (1.6%) had worsened preoperative GERD, and 26 (1.7%) had the same preoperative GERD symptoms. Antral preservation and gastropexy were protective factors against the development of GERD after LSG. LSG was converted to LRYGB in 15.8% of the patients with GERD. The response to medical treatment was observed in 300 (79.2%) patients with GERD. Conclusion Post-LSG GERD presented in 379 patients (24.7%). Antral preservation and gastropexy were protective factors for the development of postoperative GERD after LSG. Medical treatment was the main line of treatment for GERD. Trial registration ClinicalTrials.gov ID: NCT05416645. Graphical abstract
- Open Access
- 6 June 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32  (8) , 2807-2813
Single-Anastomosis Sleeve Jejunal (SAS-J) Bypass as Revisional Surgery After Primary Restrictive Bariatric Procedures
Purpose Single-anastomosis sleeve jejunal (SAS-J) bypass is the modification of a single-anastomosis sleeve ileal (SASI) bypass with a short biliary limb. SAS-J bypass is reported to be a good primary bariatric procedure. This study aimed to evaluate the results of SAS-J bypass as a revisional surgery after failed primary restrictive bariatric procedures. Material and Methods This was a prospective cohort study including 43 patients who underwent SAS-J bypass as a revisional surgery for weight regain after laparoscopic sleeve gastrectomy (LSG), laparoscopic adjustable gastric band (LAGB), or laparoscopic gastric plication. Results Of the total patients, 35 (81.4%) were female, and 8 (18.6%) were male. The mean BMI was 46.3 kg/m2. The mean age was 41 years. Thirty-two patients (74.4%) had a failed sleeve, 9 (20.9%) had a failed LAGB, and 2 (4.7%) had a failed gastric plication. The mean operative time was 104 min. Intra-abdominal bleeding occurred in 1 case (2.3%), and intraluminal bleeding occurred in 3 cases (7%). No case (0%) developed a leak. The percentage of excess weight loss (%EWL) reached 76.5% after 1 year. Type 2 diabetes mellitus remission occurred in all diabetic patients, hypertension remitted in 80%, hyperlipidemia remitted in 83.3%, and obstructive sleep apnea syndrome improved in all cases. Gastroesophageal reflux disease (GERD) symptoms were improved in 86.7% of patients. Significant biliary gastritis occurred in 4 patients (9.3%). Dumping syndrome was reported in 4 patients (9.3%). Conclusions SAS-J bypass was effective as a salvage surgery after failed restrictive bariatric procedures, but long-term follow-up is needed. Graphical abstract
- 6 June 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 32  (8) , 2807-2813
Open AccessSingle-Anastomosis Sleeve Jejunal (SAS-J) Bypass as Revisional Surgery After Primary Restrictive Bariatric Procedures
Purpose Single-anastomosis sleeve jejunal (SAS-J) bypass is the modification of a single-anastomosis sleeve ileal (SASI) bypass with a short biliary limb. SAS-J bypass is reported to be a good primary bariatric procedure. This study aimed to evaluate the results of SAS-J bypass as a revisional surgery after failed primary restrictive bariatric procedures. Material and Methods This was a prospective cohort study including 43 patients who underwent SAS-J bypass as a revisional surgery for weight regain after laparoscopic sleeve gastrectomy (LSG), laparoscopic adjustable gastric band (LAGB), or laparoscopic gastric plication. Results Of the total patients, 35 (81.4%) were female, and 8 (18.6%) were male. The mean BMI was 46.3 kg/m2. The mean age was 41 years. Thirty-two patients (74.4%) had a failed sleeve, 9 (20.9%) had a failed LAGB, and 2 (4.7%) had a failed gastric plication. The mean operative time was 104 min. Intra-abdominal bleeding occurred in 1 case (2.3%), and intraluminal bleeding occurred in 3 cases (7%). No case (0%) developed a leak. The percentage of excess weight loss (%EWL) reached 76.5% after 1 year. Type 2 diabetes mellitus remission occurred in all diabetic patients, hypertension remitted in 80%, hyperlipidemia remitted in 83.3%, and obstructive sleep apnea syndrome improved in all cases. Gastroesophageal reflux disease (GERD) symptoms were improved in 86.7% of patients. Significant biliary gastritis occurred in 4 patients (9.3%). Dumping syndrome was reported in 4 patients (9.3%). Conclusions SAS-J bypass was effective as a salvage surgery after failed restrictive bariatric procedures, but long-term follow-up is needed. Graphical abstract
- 1 June 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 102, 106662
Single anastomosis sleeve jejunal (SAS-J) bypass as a treatment for morbid obesity, technique and review of 1986 cases and 6 Years follow-up. Retrospective cohort
Santoro's operation is a sleeve gastrectomy with transit bipartition. The operation aims to maintain passage to the duodenum to minimize nutritional deficiency. This procedure is rapidly changed to single anastomosis sleeve ileal (SASI) bypass. SAS-J bypass is a modification of SASI with a short biliary limb. This study is a retrospective study of prospectively collected data. The study includes a comprehensive review of 1986 patients who underwent SAS-J bypass over 6 years. The total number is used to evaluate the perioperative data. One- and two-year follow-up was used to evaluate weight loss and comorbidities; follow-up of more than 5 years was used to obtain long-term results. In this study, 70.4% of patients were female and 29.6% were male. The mean body mass index (BMI) was 44.7. The mean age was 42 years. Regarding comorbidities, 25.8% of the patients had type 2 diabetes, 31% were hypertensive, 14.2% had sleep apnea syndrome, 6.6% had gastroesophageal reflux disease (GERD), and 39.6% had hyperlipidemia. Of the 1294 patients who complete one-year follow up, %EWL reached 87%. Blood glucose levels were normalized in 98.5% of patients, hypertension remitted in 93%, hyperlipidemia improved in 97%, SAS is improved in all cases, and GERD improved in 89% of patients. After 5 years, 94 patients' BMI decreased from 44.3 to 28.3 without significant nutritional deficiency. Laparoscopic SAS-J bypass is an effective and simple alternative bariatric procedure at short- and long-term follow-up.
- 1 June 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 102, 106662
Single anastomosis sleeve jejunal (SAS-J) bypass as a treatment for morbid obesity, technique and review of 1986 cases and 6 Years follow-up. Retrospective cohort
Santoro's operation is a sleeve gastrectomy with transit bipartition. The operation aims to maintain passage to the duodenum to minimize nutritional deficiency. This procedure is rapidly changed to single anastomosis sleeve ileal (SASI) bypass. SAS-J bypass is a modification of SASI with a short biliary limb. This study is a retrospective study of prospectively collected data. The study includes a comprehensive review of 1986 patients who underwent SAS-J bypass over 6 years. The total number is used to evaluate the perioperative data. One- and two-year follow-up was used to evaluate weight loss and comorbidities; follow-up of more than 5 years was used to obtain long-term results. In this study, 70.4% of patients were female and 29.6% were male. The mean body mass index (BMI) was 44.7. The mean age was 42 years. Regarding comorbidities, 25.8% of the patients had type 2 diabetes, 31% were hypertensive, 14.2% had sleep apnea syndrome, 6.6% had gastroesophageal reflux disease (GERD), and 39.6% had hyperlipidemia. Of the 1294 patients who complete one-year follow up, %EWL reached 87%. Blood glucose levels were normalized in 98.5% of patients, hypertension remitted in 93%, hyperlipidemia improved in 97%, SAS is improved in all cases, and GERD improved in 89% of patients. After 5 years, 94 patients' BMI decreased from 44.3 to 28.3 without significant nutritional deficiency. Laparoscopic SAS-J bypass is an effective and simple alternative bariatric procedure at short- and long-term follow-up.
- 28 September 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35  (10) , 5698-5704
The outcomes of single anastomosis sleeve jejunal bypass as a treatment for morbid obesity (Two-year follow-up)
Introduction Santoro's operation is a sleeve gastrectomy with transit bipartition. The aim of the procedure is to keep pass to the duodenum to decrease nutritional deficiency and to allow endoscopic management of obstructive jaundice. To be easier, this procedure was rapidly altered to a single anastomosis sleeve ileal bypass (SASI). In this study, we shifted the anastomosis up to the jejunum to evaluate the effect of laparoscopic single anastomosis sleeve jejunal (SASJ) bypass as a treatment for morbid obesity and related comorbidities. In addition, the effect of the SASJ procedure on nutritional deficiency was examined. Methods In this study, 150 morbidly obese patients underwent SASJ bypass with a biliary limb length of 200–250 cm. All patients were followed up at 1, 3, 6, 12, 18, and 24 months. We evaluated all cases by assessing BMI, complications, nutritional status, and obesity-related comorbidities. Results The mean age of participants was 30.6 years, and the mean body mass index (BMI) was 44.6 kg/m2. Of the patients, 35 (23.2%) had type two diabetes and 47 (31.3%) were hypertensive. Postoperative bleeding occurred in two cases (1.3%). One patient developed a gastric leak (0.7%), and five patients developed biliary gastritis (3.3%). One patient (0.7%) developed a pulmonary embolism. The %EWL reached 85% in 1 year. Normalization of blood glucose occurred within 2 months after surgery in all diabetic patients. Hypertension underwent remittance in 89% of hypertensive patients. All patients were gradually weaned from four types of multivitamin regimens to only one multivitamin regimen without apparent nutritional deficiency. Conclusions Laparoscopic SASJ bypass is an effective, safe, and simple procedure for treating morbid obesity and comorbid conditions with least nutritional deficiency. However, long-term studies are needed.
- 28 September 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35  (10) , 5698-5704
The outcomes of single anastomosis sleeve jejunal bypass as a treatment for morbid obesity (Two-year follow-up)
Introduction Santoro's operation is a sleeve gastrectomy with transit bipartition. The aim of the procedure is to keep pass to the duodenum to decrease nutritional deficiency and to allow endoscopic management of obstructive jaundice. To be easier, this procedure was rapidly altered to a single anastomosis sleeve ileal bypass (SASI). In this study, we shifted the anastomosis up to the jejunum to evaluate the effect of laparoscopic single anastomosis sleeve jejunal (SASJ) bypass as a treatment for morbid obesity and related comorbidities. In addition, the effect of the SASJ procedure on nutritional deficiency was examined. Methods In this study, 150 morbidly obese patients underwent SASJ bypass with a biliary limb length of 200–250 cm. All patients were followed up at 1, 3, 6, 12, 18, and 24 months. We evaluated all cases by assessing BMI, complications, nutritional status, and obesity-related comorbidities. Results The mean age of participants was 30.6 years, and the mean body mass index (BMI) was 44.6 kg/m2. Of the patients, 35 (23.2%) had type two diabetes and 47 (31.3%) were hypertensive. Postoperative bleeding occurred in two cases (1.3%). One patient developed a gastric leak (0.7%), and five patients developed biliary gastritis (3.3%). One patient (0.7%) developed a pulmonary embolism. The %EWL reached 85% in 1 year. Normalization of blood glucose occurred within 2 months after surgery in all diabetic patients. Hypertension underwent remittance in 89% of hypertensive patients. All patients were gradually weaned from four types of multivitamin regimens to only one multivitamin regimen without apparent nutritional deficiency. Conclusions Laparoscopic SASJ bypass is an effective, safe, and simple procedure for treating morbid obesity and comorbid conditions with least nutritional deficiency. However, long-term studies are needed.
- 1 September 2017
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 45, 29-34
Intra-capsular total thyroid enucleation versus total thyroidectomy in treatment of benign multinodular goiter. A prospective randomized controlled clinical trial
Due to high recurrence rate after subtotal thyroidectomy, most of centers have shifted to total thyroidectomy as a surgical treatment for benign multinodular goiter (BMNG), but serious complications, as laryngeal nerve affection & hypocalcaemia, are still present. This study aimed to evaluate treatment of BMNG using intra-capsular total thyroid enucleation in comparison to standard total thyroidectomy. This is a prospective randomized controlled clinical trial conducted in a hospital in the period from December 2009 to December 2015. Of total 224 patients with clinically BMNG. 112 patients operated by intracapsular total thyroid enucleation (ITTE group) and the other 112 patients operated by standard total thyroidectomy (STT group). The minimal follow up period was 36 months. The mean operative time in ITTE group was (93.7 ± 9.6 min) compared to (86.9 ± 8.3 min) in STT group. Transient recurrent laryngeal nerve (RLN) palsy was 0% in ITTE group VS 7.1% in STT group. No cases (0%) developed permanent RLN palsy in ITTE group VS 0.9% in STT group. Symptomatic transient hypocalcaemia occurred in 1.8% in ITTE group VS 11.6% in STT group. No cases (0%) developed permanent hypocalcaemia in ITTE group VS 0.9% in STT group. No recurrence (0%) in both groups after minimal 3 years of follow up. Intracapsular Total thyroid enucleation technique is safe with the least serious complications, especially RLN injury and hypoparathyroidism, with no recurrence, but this technique still not radical so couldn't be used in suspicious cases for malignancy.
- 1 September 2017
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 45, 29-34
Intra-capsular total thyroid enucleation versus total thyroidectomy in treatment of benign multinodular goiter. A prospective randomized controlled clinical trial
Due to high recurrence rate after subtotal thyroidectomy, most of centers have shifted to total thyroidectomy as a surgical treatment for benign multinodular goiter (BMNG), but serious complications, as laryngeal nerve affection & hypocalcaemia, are still present. This study aimed to evaluate treatment of BMNG using intra-capsular total thyroid enucleation in comparison to standard total thyroidectomy. This is a prospective randomized controlled clinical trial conducted in a hospital in the period from December 2009 to December 2015. Of total 224 patients with clinically BMNG. 112 patients operated by intracapsular total thyroid enucleation (ITTE group) and the other 112 patients operated by standard total thyroidectomy (STT group). The minimal follow up period was 36 months. The mean operative time in ITTE group was (93.7 ± 9.6 min) compared to (86.9 ± 8.3 min) in STT group. Transient recurrent laryngeal nerve (RLN) palsy was 0% in ITTE group VS 7.1% in STT group. No cases (0%) developed permanent RLN palsy in ITTE group VS 0.9% in STT group. Symptomatic transient hypocalcaemia occurred in 1.8% in ITTE group VS 11.6% in STT group. No cases (0%) developed permanent hypocalcaemia in ITTE group VS 0.9% in STT group. No recurrence (0%) in both groups after minimal 3 years of follow up. Intracapsular Total thyroid enucleation technique is safe with the least serious complications, especially RLN injury and hypoparathyroidism, with no recurrence, but this technique still not radical so couldn't be used in suspicious cases for malignancy.
- 1 July 2017
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 43, 75-80
Retroinfundibular laparoscopic cholecystectomy versus standard laparoscopic cholecystectomy in difficult cases
Laparoscopic cholecystectomy becomes the gold standard surgical procedure for treating gallstones. Standard laparoscopic cholecystectomy (SLC) requires proper dissection of Calot's triangle to achieve the critical view of safety. This may be difficult in certain conditions, resulting in higher incidence of bile duct injury and conversion to open. We aimed to compare the outcomes of laparoscopic cholecystectomy by retroinfundibular (RI) approach to that of SLC, in difficult cases. This study is prospective cohort study, in which 60 patients were operated by SLC and 65 patients by laparoscopic cholecystectomy by RI approach. From the total 125 cases, 95 (76%) patients were male and 30 (24%) were female. The mean age was 59.5 ± 5.5 years. The mean operative time in SLC group was 128 ± 17 min VS. 114 ± 10 min in RI group. Conversion to open occurred in 10% in SLC group VS. 1.5% in RI group. Biliary injury occurred in 3.3% in SLC group VS. 0% in RI group. The mean hospital stay in SLC was 3.7 ± 5.3 days VS. 2.1 ± 0.3 days in RI group. In difficult cholecystectomy, RI approach is feasible and safe alternative to SLC.
- 1 July 2017
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 43, 75-80
Retroinfundibular laparoscopic cholecystectomy versus standard laparoscopic cholecystectomy in difficult cases
Laparoscopic cholecystectomy becomes the gold standard surgical procedure for treating gallstones. Standard laparoscopic cholecystectomy (SLC) requires proper dissection of Calot's triangle to achieve the critical view of safety. This may be difficult in certain conditions, resulting in higher incidence of bile duct injury and conversion to open. We aimed to compare the outcomes of laparoscopic cholecystectomy by retroinfundibular (RI) approach to that of SLC, in difficult cases. This study is prospective cohort study, in which 60 patients were operated by SLC and 65 patients by laparoscopic cholecystectomy by RI approach. From the total 125 cases, 95 (76%) patients were male and 30 (24%) were female. The mean age was 59.5 ± 5.5 years. The mean operative time in SLC group was 128 ± 17 min VS. 114 ± 10 min in RI group. Conversion to open occurred in 10% in SLC group VS. 1.5% in RI group. Biliary injury occurred in 3.3% in SLC group VS. 0% in RI group. The mean hospital stay in SLC was 3.7 ± 5.3 days VS. 2.1 ± 0.3 days in RI group. In difficult cholecystectomy, RI approach is feasible and safe alternative to SLC.